FBIO offering history
Every offering-related filing in Fortress Biotech, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 880 filings back to Mar 5, 2008.
| Date | Filing | What it means | |
|---|---|---|---|
| Dec 18, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 17, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 16, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Dec 15, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 1, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Apr 2, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 2, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 2, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 2, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 25, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 7, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 7, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 27, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 23, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 23, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 20, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 2, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 25, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 28, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 27, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 27, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 20, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 31, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 30, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 29, 2024 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| May 17, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 5, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 3, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 13, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 9, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 26, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 13, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 7, 2023 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Feb 10, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 9, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 1, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 4, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 30, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 30, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 23, 2021 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
FBIO offering FAQ
When did FBIO last execute an offering?
Per SEC filings, Fortress Biotech, Inc.'s most recent priced offering document is a 8-K filed 2025-12-15. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did FBIO last announce or register an offering?
The most recent registration is a S-1 filed 2025-12-16. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.